GAIN-(L): Efficacy and biomarker findings of RG7160 (GA201), a novel, dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with first-line cisplatin and pemetrexed in metastatic nonsquamous NSCLC

被引：0
|
作者：
Spicer, James F.
Felip, Enriqueta
Bosquee, Lionel
Gregorc, Vanesa
Lopez Calderero, Iker
Martinez, Pablo
Montes, Ana
Sorlini, Cristina
Gabriele Ott, Marion
Golding, Sophie
Mariconti, Luisa
Longauer Banholzer, Maria
Passioukov, Alexandre
Carlile, David
Manenti, Luigi
Paz-Ares, Luis
机构：
[1] Kings Coll London, London WC2R 2LS, England
[2] Vall dHebron Univ Hosp, Barcelona, Spain
[3] CHU, Liege, Belgium
[4] Fdn San Raffaele del Monte Tabor, Milan, Italy
[5] Inst Biomed Sevilla IBIS, Seville, Spain
[6] Hosp Univ Virgen del Rocio, Seville, Spain
[7] Guys & St Thomas NHS Fdn Trust, London, England
[8] F Hoffmann La Roche Ltd, Basel, Switzerland
[9] Roche Glycart AG, Schlieren, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7544
引用
收藏
页数：1
相关论文
共 5 条
  • [1] GAIN-(L): Efficacy, safety and biomarker analysis of RG7160 (GA201), a novel dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with 1st line cisplatin and pemetrexed in metastatic non-squamous NSCLC
    Paz-Ares, L.
    Calvo, E.
    Kalinka-Warzocha, E.
    Cappuzzo, F.
    Corral, J.
    Guizani, C.
    Golding, S.
    Passioukov, A.
    Ott, M. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S800 - S801
  • [2] Exploratory pharmacodynamics (PD) trial to investigate the mechanism of action of RG7160 (GA201), a novel dual-acting, monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), compared with cetuximab (C) in neoadjuvant head and neck squamous cell carcinoma (HNSCC)
    Temam, Stephane
    Spicer, James F.
    Gomez-Roca, Carlos
    Berge, Yann
    Jeannon, Jean-Pierre
    Soria, Jean-Charles
    Brossard, Sophia Soehrman
    Delmar, Paul
    Golding, Sophie
    Oppenheim, David
    Passioukov, Alexandre
    Manenti, Luigi
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Correlative biomarker analysis of sequential tumor biopsies in a ph I mode of action (MoA) study in neoadjuvant head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with RG7160 (GA201), a novel dual-acting, monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), with cetuximab (C) as reference
    Mancao, Christoph
    Di Scala, Lilla
    Delmar, Paul
    Temam, Stephane
    Soria, Jean-Charles
    Spicer, James F.
    McGurk, Mark
    Delord, Jean-Pierre
    Sarini, Jerome
    Halama, Niels
    Evers, Stefan
    Passioukov, Alexandre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Long-term efficacy and pharmacodynamic parameter analysis in pretreated KRAS-mutant metastatic colorectal carcinoma (mCRC) patients treated with RG7160 (GA201), an antibody-dependent cellular cytotoxicity (ADCC)-enhanced monoclonal anti-EGFR antibody
    Delord, Jean-Pierre
    Tabernero, Josep
    Garcia-Carbonero, Rocio
    Cervantes-Ruiperez, Andres
    Gomez-Roca, Carlos Alberto
    Berge, Yann
    Capdevila, Jaume
    Jaime, Jesus Corral
    Perez, Desamparados Roda
    Golding, Sophie
    Oppenheim, David
    Brossard, Sophia Soehrman
    Mancao, Christoph
    Farzaneh, Farzin
    Passioukov, Alexandre
    Manenti, Luigi
    Ott, Marion Gabriele
    Soria, Jean-Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] GAIN-(C): Efficacy and safety analysis of imgatuzumab (GA201), a novel dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with FOLFIRI compared to cetuximab plus FOLFIRI in second-line KRAS exon 2 wild type (e2WT) or with FOLFIRI alone in mutated (e2MT) metastatic colorectal cancer (mCRC).
    Bridgewater, John A.
    Cervantes, Andres
    Markman, Ben
    Siena, Salvatore
    Cubillo, Antonio
    Garcia Carbonero, Rocio
    Sigal, Darren
    Aprile, Giuseppe
    Cunningham, David
    Nadal, Cristina
    Pericay, Carles
    Samuel, Leslie M.
    Hochhauser, Daniel
    Alejandro Perez-Fidalgo, Jose
    Strickland, Andrew
    Guizani, Cecile
    Golding, Sophie
    Lopez Valverde, Vanesa
    Ott, Marion Gabriele
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
1